Noyez L, van Eck FM, Skotnicki SH, Brouwer RM. Coronary reoperations in patients with a patent internal mammary artery graft.
CARDIOVASCULAR SURGERY (LONDON, ENGLAND) 2001;
9:179-83. [PMID:
11250188 DOI:
10.1016/s0967-2109(00)00101-0]
[Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
OBJECTIVE
Analysis of short and long term results, clinical, functional and subjective status of patients, with a patent arterial graft, after coronary reoperation (RECABG).
METHODS
Perioperative and follow-up data of 71 patients, undergoing coronary reoperations (1987--8) were studied. A cross-sectional follow-up was conducted, functional evaluation by the Duke Activity Status Index (DASI), and patient's evaluation of his life situation were registered.
RESULTS
Perioperative mortality was 7%. Eleven patients died during follow-up. The 12-month and 60-month survival was 96% and 80%. Event-free survival was 86% and 51%. Family doctors declared that 55/66 (83%) had benefitted from the coronary reoperations. New York Heart Association decreased significantly from 3.4 +/- 0.5 preoperative versus 1.5 +/- 0.4 postoperative. The mean DASI was 38.06 +/- 10.42. At the moment of the cross-sectional follow-up, 45/55 patients (82%) declared to have benefitted from the coronary reoperations.
CONCLUSION
Improvement in New York Heart Association-class, good postoperative functional capacity, and patients positive evaluation, justify coronary reoperations in patients with a patent internal mammary artery graft.
Collapse